Document is current
Any future updates will be listed below
-
Authors
Habek, Mario https://orcid.org/0000-0002-3360-1748
Fanciulli, Alessandra
Krbot Skorić, Magdalena
Thijs, Roland D.
- License Information
-
More Information
Article History
Received: 9 March 2026
Accepted: 19 March 2026
First Online: 31 March 2026
Declarations
:
: Mario Habek: Received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, Astra Zeneca, Amgen, Zentiva. Alessandra Fanciulli: Dr Fanciulli reports royalties from Springer Verlag, speaker fees and honoraria from Abbvie, Bial, CNSystems, Desitin, Elsevier, Ferrer, Ionis, Medtronic, Sanofi, Theravance Biopharma, Austrian Autonomic Society, International Parkinson Disease and Movement Disorders Society, and research grants from the Austrian Science Fund, European Reference Network for Rare Neurological Disorders, Medical University of Innsbruck, Mission MSA and Dr Johannes and Hertha Tuba Foundation, outside of the present work. Magdalena Krbot Skorić: Received consultation and/or speaker fees from Biogen, Novartis, Roche. Roland Thijs: Reports lecture and consultancy fees from Medtronic, UCB, Angelini Pharma, Eisai, Theravarance, Zogenix, Novartis, LivAssured, and Arvelle, and grants from Medtronic and NewLife Wearables.
